MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2Q2aXQa
via IFTTT